News
Readers respond to a psychiatrist’s essay arguing for more research on the effects of S.S.R.I.s like Prozac and other drugs.
20h
India Today on MSNBaby healed in world's first gene-editing therapy; Indian-origin doctor plays key roleAn Indian-origin cardiologist, Kiran Musunuru, played a key role in a groundbreaking medical milestone, helping treat a ...
Weill Cornell Medicine-Qatar (WCM-Q) has become the first medical institution in Qatar to receive official designation as an ...
4d
News-Medical.Net on MSNTirzepatide outperforms semaglutide in weight loss clinical trialTirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...
Tirzepatide promoted greater weight loss in individuals with obesity than semaglutide in a clinical trial that compared the ...
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name ...
Indian-origin cardiologist Kiran Musunuru leads breakthrough CRISPR gene editing therapy for rare genetic disorder focusing ...
5d
inews.co.uk on MSNWhy you might be given the ‘second-best’ weight loss drugAs the definitive trial comparing Wegovy to Mounjaro is released, experts stress the need for patients to be given the very ...
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...
In the 72-week trial—led by an investigator at Weill Cornell ... Medical School, the David Geffen School of Medicine at the University of California, Los Angeles, the University College Dublin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results